Creatine increases the spread of cancer by activating platelets, which then help cancer cells travel to other parts of the body. This happens through an indirect mechanism involving platelets, not through direct effects on cancer cells.
From A New Study Just Linked Creatine To Cancer · videoSee the scientific wording
Creatine promotes cancer metastasis by activating platelets, an indirect mechanism, rather than by directly affecting tumor cells.
Correlational — new studies may shift this
Observational2 low-scoring studies link this claim to the outcome, but causation is not established.
What the research says
2 studies reviewedSupporting (1)
Cross-Sectional StudyHuman2026
This study shows that taking creatine can make cancer spread more by making platelets more active, which helps cancer cells travel through the blood to new places. This happens because creatine changes the behavior of platelets, not by directly affecting cancer cells.
Contradicting (1)
Creatine promotes cancer metastasis through activation of Smad2/3.
Cohort StudyAnimal2021
The study shows that creatine helps cancer spread by directly acting on cancer cells, not by activating platelets as the claim suggests, so the claim is wrong about how it happens.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Creatine from diet or supplements gets into bone marrow cells that make platelets. Inside these cells, creatine turns on a protein called creatine kinase B. This protein activates another protein, STAT5B, which flips switches inside the cell to make more of the proteins that make platelets super active. These hyperactive platelets then help cancer cells spread through the blood to new places in the body.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting, 1 contradicting studies
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Creatine increases the spread of cancer by activating platelets, which then help cancer cells travel to other parts of the body. This happens through an indirect mechanism involving platelets, not through direct effects on cancer cells.
Mechanism
2 studiesThe body has two ways creatine helps cancer spread. One way: creatine makes platelets hyperactive, and these platelets carry cancer cells through the blood to new spots. Another way: creatine enters cancer cells directly and turns on genes that let them move and invade. Both ways have evidence, so the claim that creatine works only through platelets is not fully supported.
Creatine from diet or supplements gets into bone marrow cells that make platelets. Inside these cells, creatine turns on a protein called creatine kinase B. This protein activates another protein, STAT5B, which flips switches inside the cell to make more of the proteins that make platelets super active. These hyperactive platelets then help cancer cells spread through the blood to new places in the body.
Creatine supplementation increases creatine levels in megakaryocytes.
Elevated creatine levels upregulate creatine kinase B (CKB) in megakaryocytes.
CKB phosphorylates STAT5B in a non-canonical manner.
Phosphorylated STAT5B activates transcription of platelet functional genes.
Increased expression of platelet functional genes results in hyperactive platelets.
Hyperactive platelets promote tumor metastasis by aiding cancer cell survival and dissemination in the bloodstream.
Less supported by current evidence, but not ruled out
Creatine, either from food or made by the body, enters cancer cells and turns on a protein called MPS1. MPS1 then activates two other proteins, Smad2 and Smad3, which travel to the nucleus and turn on genes for Snail and Slug. These genes make the cancer cells more mobile and invasive, allowing them to break away from the original tumor and spread to other organs.
Creatine (dietary or synthesized by GATM in tumor cells) activates MPS1 kinase.
MPS1 phosphorylates Smad2 and Smad3.
Phosphorylated Smad2/3 upregulate transcription of Snail and Slug.
Increased Snail and Slug expression promotes epithelial-to-mesenchymal transition, enhancing cancer cell invasion and metastasis.
Evidence from Studies
Last searched 2mo ago
Supporting (1)
Community contributions welcome
Exogenous creatine supplementation promotes tumor metastasis via megakaryocyte creatine kinase B-STAT5B signaling.
This study shows that taking creatine can make cancer spread more by making platelets more active, which helps cancer cells travel through the blood to new places. This happens because creatine changes the behavior of platelets, not by directly affecting cancer cells.
Contradicting (1)
Community contributions welcome
Creatine promotes cancer metastasis through activation of Smad2/3.
The study shows that creatine helps cancer spread by directly acting on cancer cells, not by activating platelets as the claim suggests, so the claim is wrong about how it happens.
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of Creatine Supplementation and Cancer Metastasis Risk in Human Studies
Comprehensive search of RCTs, cohort studies, and case-control studies in human cancer patients or populations, with meta-analysis of effect estimates for metastasis incidence or progression, stratified by platelet-related biomarkers.
Double-Blind Randomized Placebo-Controlled Trial of Creatine Supplementation in Patients with Early-Stage Cancer
Randomized double-blind trial comparing creatine (e.g., 5g/day) vs placebo in cancer patients (e.g., breast, colon, etc.) followed for 2 years for metastasis occurrence. Include platelet activation markers as secondary outcomes.
Prospective Cohort Study of Creatine Use and Metastasis in Colorectal Cancer Survivors
Prospective cohort of cancer survivors (e.g., colorectal cancer) with documented creatine supplementation, followed for 5 years for metastasis development, adjusting for confounders.
Mouse Model Study of Creatine-Induced Platelet Activation and Metastasis in Melanoma
Mouse melanoma metastasis model (e.g., intravenous injection of B16 melanoma cells) with creatine supplementation (e.g., 1% in diet) vs control, measuring platelet activation markers and lung metastasis colonies.